LGALS1 and central nervous system cancer: Using the NanoString technology, we found that LGALS1 mRNA levels were lower in the four aforementioned cell lines, as well as in the control normal human astrocytes, than in two H-1PV-sensitive glioma cell lines (NCH125 and NCH37) (Figure 9A).